Financials
Income statement
Fiscal date | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
---|---|---|---|---|
Total reported revenue | 165.6B | 180.6B | 169.6B | 169.3B |
Cost of revenue | 124.3B | 136.2B | 127.3B | 126.8B |
Gross profit | 41.3B | 44.4B | 42.2B | 42.5B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | 36.5B | 35.5B | 34.6B |
Other operating expenses | 34.2B | 36.5B | 35.5B | 34.6B |
Operating income | 7.1B | 7.9B | 6.7B | 7.9B |
Non operating interest income | ||||
Income | 93M | 115M | 140M | 114M |
Expense | 637M | 717M | 618M | 679M |
Other income expense | -597M | -294M | -132M | -1.2B |
Pretax income | 6.0B | 7.0B | 6.1B | 6.2B |
Tax provision | 1.4B | 1.5B | 1.4B | 1.5B |
Net income | 4.6B | 5.4B | 4.7B | 4.7B |
Basic EPS | 0.6 | — | 0.6 | 0.6 |
Diluted EPS | 0.6 | — | 0.6 | 0.6 |
Basic average shares | 8.0B | — | 8.0B | 8.0B |
Diluted average shares | 8.1B | — | 8.1B | 8.1B |
EBITDA | 10B | 11.1B | 10.0B | 10.1B |
Net income from continuing op. | 4.6B | 5.4B | 4.7B | 4.7B |
Minority interests | -152M | -171M | -137M | -210M |
Preferred stock dividends | — | — | — | — |